The Federal Perspective on Coverage of Medications to Treat Obesity: Considerations From the Congressional Budget Office
Presentation
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop on GLP-1-Based Therapies.
This presentation describes how CBO would assess the budgetary effects of a policy that allows Medicare coverage of medications to treat obesity. The presentation also discusses areas of research that would help inform CBO’s analyses.
